title: The role of the central noradrenergic system in behavioral inhibition.
abstract: Although the central noradrenergic system has been shown to be involved in a number of behavioral and neurophysiological processes, the relation of these to its role in depressive illness has been difficult to define. The present review discusses the hypothesis that one of its chief functions that may be related to affective illness is the inhibition of behavioral activation, a prominent symptom of the disorder. This hypothesis is found to be consistent with most previous neuropsychopharmacological and immunohistochemical experiments on active behavior in rodents in a variety of experimental conditions using manipulation of neurotransmission at both locus coeruleus and forebrain adrenergic receptors. The findings support a mechanism in which high rates of noradrenergic neural activity suppress the neural activity of principal neurons in forebrain regions mediating active behavior. The suppression may be mediated through postsynaptic galaninergic and adrenergic receptors, and via the release of corticotrophin-releasing hormone. The hypothesis is consistent with clinical evidence for central noradrenergic system hyperactivity in depressives and with the view that this hyperactivity is a contributing etiological factor in the disorder. A similar mechanism may underlie the ability of the noradrenergic system to suppress seizure activity suggesting that inhibition of the spread of neural activation may be a unifying function.
authors.affiliation: Department of Psychiatry, New York University Langone School of Medicine, 550 First Ave., New York, NY 10016, USA. eric.stone@nyumc.org
authors.forename: Eric A
authors.initials: EA
authors.lastname: Stone
authors.forename: Yan
authors.initials: Y
authors.lastname: Lin
authors.forename: Yasmeen
authors.initials: Y
authors.lastname: Sarfraz
authors.forename: David
authors.initials: D
authors.lastname: Quartermain
mesh_terms: D059331:Adrenergic Neurons / Q000473:pathology / Q000502:physiology*; D000818:Animals; D003866:Depressive Disorder / Q000473:pathology* / Q000523:psychology; D006801:Humans; D007266:Inhibition, Psychological; D008125:Locus Coeruleus / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D009433:Neural Inhibition / Q000502:physiology; D009434:Neural Pathways / Q000166:cytology / Q000473:pathology